Cargando…
Bone marrow-derived CD13(+) cells sustain tumor progression: A potential non-malignant target for anticancer therapy
Non-malignant cells found within neoplastic lesions express alanyl (membrane) aminopeptidase (ANPEP, best known as CD13), and CD13-null mice exhibit limited tumor growth and angiogenesis. We have recently demonstrated that a subset of bone marrow-derived CD11b(+)CD13(+) myeloid cells accumulate with...
Autores principales: | Dondossola, Eleonora, Corti, Angelo, Sidman, Richard L, Arap, Wadih, Pasqualini, Renata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203577/ https://www.ncbi.nlm.nih.gov/pubmed/25339996 http://dx.doi.org/10.4161/onci.27716 |
Ejemplares similares
-
Brain endothelial cell‐targeted gene therapy of neurovascular disorders
por: Marchiò, Serena, et al.
Publicado: (2016) -
Subversion of the chemotherapy-induced anticancer immune response by the ecto-ATPase CD39
por: Michaud, Mickaël, et al.
Publicado: (2012) -
Does the RAAS play a role in loss of taste and smell during COVID-19 infections?
por: Luchiari, Heloise R., et al.
Publicado: (2020) -
Biomimetic human bone marrow tissues: models to study hematopoiesis and platforms for drug testing
por: García-García, Andrés, et al.
Publicado: (2021) -
Under one roof: The bone marrow survival niche for multiple myeloma and normal plasma cells
por: Nair, Jayakumar R., et al.
Publicado: (2012)